Red blood cell transfusion is associated with decreased in-hospital muscle strength among critically ill patients requiring mechanical ventilation

Journal of Critical Care

Volumn 28, Issue 6, 2013, Pages 1079-1085

  Parsons, Elizabeth C ^a,b   Kross, Erin K ^b   Ali, Naeem A ^c   Vandevusse, Lisa K ^b   Caldwell, Ellen S ^b   Watkins, Timothy R ^b,d   Heckbert, Susan R ^e   Hough, Catherine L ^b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d PUGET SOUND BLOOD CENTER   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Erythrocyte transfusion; Hand strength; Intensive care; Muscle weakness; Respiratory distress syndrome

Indexed keywords

ADULT; APACHE; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DYNAMOMETRY; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; GRIP STRENGTH; HOSPITAL ADMISSION; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PARESIS; PATIENT SAFETY; RISK FACTOR; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE;

ERYTHROCYTE TRANSFUSION; HAND STRENGTH; INTENSIVE CARE; MUSCLE WEAKNESS; RESPIRATORY DISTRESS SYNDROME;

APACHE; CRITICAL ILLNESS; ERYTHROCYTE TRANSFUSION; FEMALE; HAND STRENGTH; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; ORGAN DYSFUNCTION SCORES; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RISK FACTORS;

EID: 84887409331     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2013.06.020     Document Type: Article

References (30)

1. De Jonghe B., Sharshar T., Lefaucheur J.P., et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002, 288:2859-2867.
2. Leijten F.S., Harinck-de Weerd J.E., Poortvliet D.C., et al. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 1995, 274:1221-1225.
3. Hermans G., Schrooten M., Van Damme P., et al. Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study. Crit Care 2009, 13:R5.
4. Hough C.L., Steinberg K.P., Thompson B.T., et al. Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med 2009, 35:63-68.
5. Corwin H.L.G.A., Pearl R.G., Fink M.P., Levy M.M., Abraham E., MacIntyre N.R., Shabot M.M., Duh M.S., Shapiro M.J. The CRIT Study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004, 32:39-52.
6. Hebert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340:409-417.
7. Rivers E.N.B., Havstad S., Ressler J., Muzzin A., Knoblich B., Peterson E., Tomlanovich M. Early Goal-Directed Therapy Collaborative Group: early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
8. Parsons E.C., Hough C.L., Seymour C.W., et al. Red blood cell transfusion and outcomes in patients with acute lung injury, sepsis and shock. Crit Care 2011, 15:R221.
9. Park D.W., Chun B.C., Kwon S.S., et al. Red blood cell transfusions are associated with lower mortality in patients with severe sepsis and septic shock: a propensity-matched analysis*. Crit Care Med 2012, 40:3140-3145.
10. Moore F.A., Moore E.E., Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 1997, 132:620-624. [discussion 624-25].
11. Gong M.N., Thompson B.T., Williams P., et al. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 2005, 33:1191-1198.
12. Koch C.G., Khandwala F., Li L., et al. Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg 2006, 82:13-20.
13. Warner M.A., O'Keeffe T., Bhavsar P., et al. Transfusions and long-term functional outcomes in traumatic brain injury. J Neurosurg 2010, 113:539-546.
14. Hod E.A., Zhang N., Sokol S.A., et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood 2010, 115:4284-4292.
15. Visser M., Pahor M., Taaffe D.R., et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 2002, 57:M326-M332.
16. Puthucheary Z., Montgomery H., Moxham J., et al. Structure to function: muscle failure in critically ill patients. J Physiol 2010, 588:4641-4648.
17. Hough C.L., Swersie H.J., Caldwell E.S., et al. Hospital and 6 month outcomes of ICU acquired neuromuscular dysfunction in patients with acute lung injury. Am J Respir Crit Care Med 2010, 181:A5357.
18. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
19. Ali N.A., O'Brien J.M., Hoffmann S.P., et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 2008, 178:261-268.
20. Mathiowetz V., Kashman N., Volland G., et al. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 1985, 66:69-74.
21. Hough C.L., Lieu B.K., Caldwell E.S. Manual muscle strength testing of critically ill patients: feasibility and interobserver agreement. Crit Care 2011, 15:R43.
22. Bates B. The nervous system: a guide to physical examination and history taking 1991, J. B. Lippincott Company, Philadelphia. 5th ed.
23. Stevens R.D., Dowdy D.W., Michaels R.K., et al. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 2007, 33:1876-1891.
24. Shorr A.F., Jackson W.L., Kelly K.M., et al. Transfusion practice and blood stream infections in critically ill patients. Chest 2005, 127:1722-1728.
25. Crossland H., Constantin-Teodosiu D., Gardiner S.M., et al. A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle. J Physiol 2008, 586:5589-5600.
26. Jackman R.W., Kandarian S.C. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 2004, 287:C834-C843.
27. Medina E.A., Afsari R.R., Ravid T., et al. Tumor necrosis factor-{alpha} decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Endocrinology 2005, 146:2726-2735.
28. Kao R., Xenocostas A., Rui T., et al. Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis model. Crit Care 2007, 11:R58.
29. Papazian L., Forel J.M., Gacouin A., et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010, 363:1107-1116.
30. Khan H., Belsher J., Yilmaz M., et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007, 131:1308-1314.